Histidine-Tryptophan-Ketoglutarate Solution versus Blood Cardioplegia in Cardiac Surgery: A Propensity-Score Matched Analysis
DOI:
https://doi.org/10.1532/hsf.1920Keywords:
Cardiac surgery, Histidine–tryptophan–ketoglutarate solution, blood cardioplegia, myocardial protectionAbstract
Background: Choosing a cardioplegic solution is a significant issue in modern cardiac surgery. Although different options are available, the optimal strategy for myocardial protection has not been established. The aim of this study was to compare intraoperative and postoperative effects of histidine–tryptophan–ketoglutarate (HTK) solution with those of standard blood cardioplegia with St Thomas No 2 solution. The study was conducted using a large cohort of adult patients undergoing complex cardiac surgery.
Methods: This study was a single center retrospective review of prospectively collected data. Between January 2008 and December 2015, 4480 patients underwent cardiac surgery using cardiopulmonary bypass (CPB) and cardioplegic arrest. Patients were divided into a blood cardioplegia group (n = 3852) and an HTK solution group (n = 628). Propensity score matching was used to adjust for differences between the two groups, and 292 matched pairs were identified. The primary end point was Intensive Care Unit (ICU) length of stay (LOS). Secondary end points included intraoperative changes in serum sodium concentration, readmission to ICU, transfusion of blood products, 30-day hospital readmission, 30-day mortality, and the incidence of major postoperative complications.
Results: No significant differences were found between the matched groups with regard to baseline characteristics. Aortic cross-clamp and CPB times were longer for the blood cardioplegia (147.4 versus 132.8 min; P < .001). Administration of HTK solution was associated with acute and transient hyponatremia (141 versus 130 mmol/L; P < .001). ICU LOS was comparable between the groups (5.4 versus 5.4 days;
P = .585). No significant differences were noted in any other secondary end point.
Conclusions: During complex cardiac surgery, both cardioplegia techniques were equivalent in terms of early
clinical outcomes.
References
arsaether E, Stenberg TA, Jakobsen Ø, et al. 2009. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas’ and histidine-tryptophan-ketoglutarate cardioplegia: an experimental comparative study in pigs. Interact Cardiovasc Thorac Surg 9:635-9.
Arslan A, Sezgin A, Gultekin B, et al. 2005. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection. Transplant Proc 37:3219-22.
Braathen B, Jeppsson A, Scherstén H, et al. 2011. One single dose of histidine-tryptophan-ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg 141:995-1001.
Bretschneider HJ. 1980. Myocardial protection. Thorac Cardiovasc Surg 28:295-302.
Chambers DJ. 2003. Mechanisms and alternative methods of achieving cardiac arrest. Ann Thorac Surg 75:S661-6.
De Palo M, Guida P, Mastro F, et al. 2017. Myocardial protection during minimally invasive cardiac surgery through right mini-thoracotomy. Perfusion 32:245-52.
Demmy TL, Molina JE, Ward HB, et al. 2008. Custodiol versus Plegisol: a phase 3 multicentre myocardial protection study. Int J Angiol 17:149-53.
Edelman JJ, Seco M, Dunne B, et al. 2013. Custodiol for myocardial protection and preservation: a systematic review. Ann Cardiothorac Surg 2:717-28.
Fannelop T, Dahle GO, Salminen PR, et al. 2009. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig. Ann Thorac Surg 87:1205-13.
Fridell JA, Mangus RS, Tector AJ. 2009. Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: a review of recent literature. Clin Transplant 23:305-12.
Garbade J, Davierwala P, Seeburger J, et al. 2013. Myocardial protection during minimally invasive mitral valve surgery: strategies and cardioplegic solutions. Ann Cardiothorac Surg. 2013;2:803-8.
Gaudino M, Pragliola C, Anselmi A, et al. 2013. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery. Scand Cardiovasc J 47:359-67.
Hoyer A, Lehmann S, Mende M, et al 2017. Custodiol versus cold calafiore for elective cardiac arrest in isolated aortic valve replacement: a propensity-matched analysis of 7263 patients. Eur J Cardiothorac Surg 52:303-9.
Hummel BW, Buss RW, DiGiorgi PL, et al. 2016. Myocardial protection and financial considerations of Custodiol cardioplegia in minimally invasive and open valve surgery. Innovations (Phila) 11:420-4.
Jynge P, Hearse DJ, Feuvray D, et al. 1981. The st. thomas’ hospital cardioplegic solution: a characterization in two species. Scand J Thorac Cardiovasc Surg Suppl 30:1-28.
Karthik S, Grayson AD, Oo AY, et al. 2004. A survey of current myocardial protection practices during coronary artery bypass grafting. Ann R Coll Surg Engl 86:413-15.
Kim JT, Park YH, Chang YE, et al. 2011. The effect of cardioplegic solution-induced sodium concentration fluctuation on post-operative seizure in pediatric cardiac patients. Ann Thorac Surg 91:1943-8.
Lindner G, Zapletal B, Schwarz C, et al. 2012. Acute hyponatremia after cardioplegia by histidine-tryptophane-ketoglutarate: a retrospective study. J Cardiothorac Surg 7:52.
Lueck S, Preusse CJ, Welz A. 2013. Clinical relevance of HTK-induced hyponatremia. Ann Thorac Surg 95:1844-5.
Matzelle SJ, Murphy MJ, Weightman WM, et al. 2014. Minimally invasive mitral valve surgery using single dose antegrade custodiol cardioplegia. Heart Lung Circ 23:863-8.
Prathanee S, Kuptanond C, Intanoo W, et al. 2015. Custodiol-HTK solution for myocardial protection in CABG patients. J Med Assoc Thai 98:S164-7.
Sansone F, Punta G, Parisi F, et al. 2012. Right minithoracotomy versus full sternotomy for the aortic valve replacement: preliminary results. Heart Lung Circ 21:169-73.
Scrascia G, Guida P, Rotunno C, et al. 2011. Myocardial protection during aortic surgery: comparison between Bretschneider-HTK and cold blood cardioplegia. Perfusion 26:427-33.
Viana FF, Shi WY, Hayward PA, et al. 2013. Custodiol versus blood cardioplegia in complex cardiac operations: an australian experience. Eur J Cardiothorac Surg 43:526-31.
Wiesenack C, Liebold A, Philipp A, et al. 2004. Four years’ experience with a miniaturized extracorporeal circulation system and its influence on clinical outcome. Artif Organs 28:1082-8.
Yamamoto H, Yamamoto F. 2013. Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics. Gen Thorac Cardiovasc Surg 61:485-96.
